PrednisoneLack of efficacy following off-label use

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2005卷 / 1期

关键词：

D O I：

10.1007/s40278-024-57797-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：704 / 704

相关论文

共 50 条

[21] AtomoxetineVarious toxicities and lack of efficacy following off-label use
Reactions Weekly, 2024, 2000 (1) : 61 - 61
[22] HydroxychloroquineLack of efficacy following an off-label use: case report
Reactions Weekly, 2021, 1858 (1) : 182 - 182
[23] OcrelizumabLack of efficacy following off-label use: case report
Reactions Weekly, 2025, 2055 (1) : 283 - 283
[24] MethylprednisoloneLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1902 (1) : 280 - 280
[25] Multiple drugsLack of efficacy and thyroiditis following off-label use
Reactions Weekly, 2023, 1988 (1) : 124 - 124
[26] Cyclophosphamide/Prednisone/ThalidomideLack of efficacy following off-label use
Reactions Weekly, 2024, 2016 (1) : 156 - 156
[27] EribulinLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1921 (1) : 135 - 135
[28] RuxolitinibLack of efficacy following off-label use: case report
Reactions Weekly, 2024, 2039 (1) : 502 - 502
[29] OmalizumabLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1956 (1) : 409 - 409
[30] LorazepamLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1919 (1) : 354 - 354

← 1 2 3 4 5 →